Quantitative HBeAg varies across the different phases of HBV infection, and can predict treatment outcome in the setting of HBV-reactivation driven by iatrogenic immunosuppression
Titel:
Quantitative HBeAg varies across the different phases of HBV infection, and can predict treatment outcome in the setting of HBV-reactivation driven by iatrogenic immunosuppression
Auteur:
Piermatteo, L. Salpini, R. Alkhatib, M. Bertoli, A. Iuvara, A. De Cristofaro, M. Cappiello, G. Cerva, C. Minichini, C. Pisaturo, M. Starace, M. Coppola, N. Fontana, C. Sarmati, L. Andreoni, M. Angelico, M. Grelli, S. Silberstein, F. Ceccherini Perno, C.F. Svicher, V.